Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinoma.

Histopathology - 1 May 2014

Allo Ghassan, Bandarchi Bizhan, Yanagawa Naoki, Wang Ami, Shih Warren, Xu Jing, Dalby Morgan, Nitta Hiroaki, To Christine, Liu Ni, Sykes Jenna, Tsao Ming S

Abstract excerpt

AIMS: We investigated the sensitivity and specificity of two novel Epidermal growth factor receptor (EGFR) mutation-specific antibodies in the detection of the most common EGFR mutations in lung adenocarcinoma. METHODS AND RESULTS: A total of 241 resected lung adenocarcinoma specimens and six resected post-neoadjuvant gefitinib adenocarcinomas were analysed for EGFR mutation using mass spectrometry, fragment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Antibodies

Share to ErbB Receptors

Share to Immunohistochemistry

Share to Lung Neoplasms

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 24251405
DOI: 10.1111/his.12331

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinoma.PMID 24251405Read ↗

Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR.Semantic proximity Read ↗

EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma.Semantic proximity Read ↗

Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer.Semantic proximity Read ↗

Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutations.Semantic proximity Read ↗

Immunostaining with EGFR mutation-specific antibodies: a reliable screening method for lung adenocarcinomas harboring EGFR mutation in biopsy and resection samples.Semantic proximity Read ↗

Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma.Semantic proximity Read ↗

Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies.Semantic proximity Read ↗

EGFR mutation-specific antibodies in pulmonary adenocarcinoma: a comparison with DNA direct sequencing.Semantic proximity Read ↗

Diamond: immunohistochemistry versus sequencing in EGFR analysis of lung adenocarcinomas.Semantic proximity Read ↗

High specificity but low sensitivity of mutation-specific antibodies against EGFR mutations in non-small-cell lung cancer.Semantic proximity Read ↗

Immunohistochemical detection of mutated epidermal growth factor receptors in pulmonary adenocarcinoma.Semantic proximity Read ↗

Immunohistochemistry with a novel mutation-specific monoclonal antibody as a screening tool for the EGFR L858R mutational status in primary lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.